David C. Hastings
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David C. Hastings
David C. Hastings was last confirmed as CFO at Arbutus Biopharma Corp (ABUS) in a filing dated April 10, 2024. The proxy statement of Arbutus Biopharma Corp reports total compensation of $2,218,362 for David C. Hastings in fiscal 2025, including a base salary of $138,613. Disclosed compensation is on record for 6 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2024-04-10
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Arbutus Biopharma Corp (ABUS) | Former Chief Financial Officer | $138,613 | $2,218,362 |
| 2024 | Arbutus Biopharma Corp (ABUS) | Former Chief Financial Officer | $502,000 | $1,825,846 |
| 2023 | Arbutus Biopharma Corp (ABUS) | Former Chief Financial Officer | $477,000 | $1,556,806 |
| 2021 | Arbutus Biopharma Corp (ABUS) | Chief Financial Officer | $437,100 | $1,456,535 |
| 2019 | Arbutus Biopharma Corp (ABUS) | Chief Financial Officer | $412,000 | $1,010,250 |
| 2018 | Arbutus Biopharma Corp (ABUS) | Chief Financial Officer | $224,000 | $1,452,867 |
Recent activity
No call appearances or filed executive changes recorded yet.